Cargando…
IFNβ1 secreted by breast cancer cells undergoing chemotherapy reprograms stromal fibroblasts to support tumour growth after treatment
Chemotherapy (CTX) remains the standard of care for most aggressive tumours, including breast cancer (BC). In BC chemotherapeutic regimens, the maximum tolerated dose of cytotoxic drugs is administered at regular intervals, and cancer cells can re‐grow or adapt during the resting periods between cyc...
Autores principales: | Maia, Ana, Gu, Zuguang, Koch, André, Berdiel‐Acer, Mireia, Will, Rainer, Schlesner, Matthias, Wiemann, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096792/ https://www.ncbi.nlm.nih.gov/pubmed/33476079 http://dx.doi.org/10.1002/1878-0261.12905 |
Ejemplares similares
-
Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts
por: Berdiel-Acer, Mireia, et al.
Publicado: (2021) -
PRL-3 overexpression in epithelial cells is induced by surrounding stromal fibroblasts
por: Molleví, David G, et al.
Publicado: (2009) -
Disentangling ERBB Signaling in Breast Cancer Subtypes—A Model-Based Analysis
por: Kemmer, Svenja, et al.
Publicado: (2022) -
Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts
por: Avagliano, Angelica, et al.
Publicado: (2018) -
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
por: Gonçalves-Ribeiro, Samuel, et al.
Publicado: (2016)